These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22820601

  • 1. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
    Li Q, Ye M, Xiao W, Zhu J, Zhang S.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
    [Abstract] [Full Text] [Related]

  • 2. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [Abstract] [Full Text] [Related]

  • 3. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD, Thrombopoietin Clinical Trail Cooperation Group.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):397-400. PubMed ID: 15061993
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH, Chen ZW, Ye XY, Lu S.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 02; 30(9):716-9. PubMed ID: 19173920
    [Abstract] [Full Text] [Related]

  • 5. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
    Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS.
    J Clin Oncol; 2003 Aug 15; 21(16):3158-67. PubMed ID: 12915607
    [Abstract] [Full Text] [Related]

  • 6. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF, Yu J, Liu L, Wu G.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug 15; 30(8):623-5. PubMed ID: 19102944
    [Abstract] [Full Text] [Related]

  • 7. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY, Feng FY, Song ST, Wang HQ, Zhang MH, Liu J, Liu XY, Xu LG, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2005 Jun 15; 27(6):373-6. PubMed ID: 16117903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia].
    Lei W, Liang J, Chen WG, Ma XZ, Xu M, Du LL.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 15; 28(7):542-4. PubMed ID: 17147124
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
    Wang Y, Wang Z, Wu L, Zhang J, Wang J, Yan L.
    Ann Hematol; 2013 Dec 15; 92(12):1695-9. PubMed ID: 23778995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV, Fay J.
    Bone Marrow Transplant; 2001 Feb 15; 27(3):261-8. PubMed ID: 11277173
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
    Tang G, Wang XM, Meng JX, Luan CL, Chen JF, Wu YQ, Zhang XN, He ZY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb 15; 26(1):234-238. PubMed ID: 29397850
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.